MSJCX
Price
$15.92
Change
+$0.03 (+0.19%)
Updated
Dec 20 closing price
SMCWX
Price
$67.91
Change
-$0.02 (-0.03%)
Updated
Dec 20 closing price
Ad is loading...

MSJCX vs SMCWX

Header iconMSJCX vs SMCWX Comparison
Open Charts MSJCX vs SMCWXBanner chart's image
Morgan Stanley Global Endurance C
Price$15.92
Change+$0.03 (+0.19%)
VolumeN/A
CapitalizationN/A
American Funds SMALLCAP World A
Price$67.91
Change-$0.02 (-0.03%)
VolumeN/A
CapitalizationN/A
MSJCX vs SMCWX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MSJCX vs. SMCWX commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MSJCX is a Hold and SMCWX is a Buy.

FUNDAMENTALS
Fundamentals
SMCWX has more cash in the bank: 73.6B vs. MSJCX (28.1M). MSJCX pays higher dividends than SMCWX: MSJCX (1.03) vs SMCWX (0.61). MSJCX was incepted earlier than SMCWX: MSJCX (6 years) vs SMCWX (35 years). MSJCX is a more actively managed with annual turnover of: 130.00 vs. SMCWX (29.00). SMCWX has a lower initial minimum investment than MSJCX: SMCWX (250) vs MSJCX (1000). MSJCX annual gain was more profitable for investors over the last year : 5.01 vs. SMCWX (4.27). MSJCX return over 5 years is better than : 25.54 vs. SMCWX (12.92).
MSJCXSMCWXMSJCX / SMCWX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence6 years35 years-
Gain YTD5.2913.117170%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets28.1M73.6B0%
Annual Yield % from dividends1.030.61167%
Returns for 1 year5.014.27118%
Returns for 3 years-40.50-11.74345%
Returns for 5 years25.5412.92198%
Returns for 10 yearsN/A38.25-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
QS5.020.29
+6.13%
QuantumScape Corp
TRU95.112.16
+2.32%
TransUnion
RDWR22.580.47
+2.13%
Radware Ltd
PTMN16.35N/A
N/A
Portman Ridge Finance Corp
PMCB1.64N/A
N/A
PharmaCyte Biotech